We conducted an observational study to compare the serum FGF19 levels between the patients with T2D and healthy controls and to analyse the association of serum FGF19 levels with baPWV and FGF19 levels with AIP in patients with T2D. This evidence concerns the gene FGF19 and autoimmune pancreatitis.